0000899243-22-014353.txt : 20220408
0000899243-22-014353.hdr.sgml : 20220408
20220408162749
ACCESSION NUMBER: 0000899243-22-014353
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220406
FILED AS OF DATE: 20220408
DATE AS OF CHANGE: 20220408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Wei Wei
CENTRAL INDEX KEY: 0001919307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40947
FILM NUMBER: 22817349
MAIL ADDRESS:
STREET 1: C/O LIANBIO
STREET 2: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LianBio
CENTRAL INDEX KEY: 0001831283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 486-2308
MAIL ADDRESS:
STREET 1: 103 CARNEGIE CENTER DRIVE, SUITE 309
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-04-06
0
0001831283
LianBio
LIAN
0001919307
Chen Wei Wei
C/O LIANBIO
103 CARNEGIE CENTER DRIVE, SUITE 309
PRINCETON
NJ
08540
1
0
0
0
Stock Option (Right to Buy)
4.95
2022-04-06
4
A
0
72600
0.00
A
2032-04-06
Ordinary Shares
72600
72600
D
1/36 of the shares underlying the option will become exercisable on 05/06/2022; the remainder shall vest and become exercisable in 35 equal monthly installments such that the option shall be fully vested on 04/06/2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.
By: /s/ Angela Chen, Attorney-in-Fact
2022-04-08